Thermo Fisher (TMO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Core Viewpoint - Thermo Fisher Scientific (TMO) is expected to report a quarterly earnings per share (EPS) of $5.25, reflecting a 7.7% decline year-over-year, while revenues are forecasted to increase by 0.7% to $10.64 billion [1] Revenue Estimates - Analysts project 'Revenues- Laboratory Products and Biopharma Services' to be $5.67 billion, indicating a year-over-year decrease of 1% [2] - The estimated 'Revenues- Specialty Diagnostics' is $1.10 billion, reflecting a year-over-year increase of 1.3% [2] - 'Revenues- Life Sciences Solutions' is expected to reach $2.47 billion, showing a year-over-year increase of 1.7% [2] Geographic Revenue Estimates - 'Revenues- Analytical Instruments' is projected to be $1.85 billion, indicating a year-over-year increase of 5.5% [3] - 'Geographic Revenues- Customer Location- North America' is expected to be $5.64 billion, reflecting a decrease of 0.4% from the prior year [3] - 'Geographic Revenues- Customer Location- Asia-Pacific' is forecasted at $1.94 billion, indicating a year-over-year increase of 1.4% [3] - 'Geographic Revenues- Customer Location- Other regions' is estimated to reach $359.04 million, reflecting a year-over-year increase of 2.6% [3] - 'Geographic Revenues- Customer Location- Europe' is projected to be $2.70 billion, indicating a year-over-year increase of 2.2% [3] Stock Performance - Shares of Thermo Fisher have shown a return of -3.4% over the past month, contrasting with the Zacks S&P 500 composite's increase of 3.8% [3]